bTECH Competitors and Similar CompaniesClear all
KalVista Pharmaceuticals's competitors and similar companies include Fractyl Health.
 KalVista Pharmaceuticals KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME). |  Fractyl Health Fractyl Health (formerly known as Fractyl Laboratories) is a metabolic therapeutics company that develops therapies for treating type 2 diabetes (T2D) and obesity. | |
Founding Date | Founding Date 2011 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Porton Down, GB HQ Cambridge, US | Locations Burlington, US HQ |
Employees | Employees 150 | Employees 88 |
Valuation ($) | Valuation ($) 523.4 m | Valuation ($) 163 m |
Financial | ||
Net income | Net income ($109.5m) (FY, 2025) | Net income ($141m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 46.2m | Total funding raised $ 190.1m |
For sources of this data, please see the company profile
View Company Profiles
Fractyl Health
HQ
Burlington, US
Employees
88
Fractyl Health (formerly known as Fractyl Laboratories) is a metabolic therapeutics company that develops therapies for treating type 2 diabetes (T2D) and obesity.
View company